Resource category: Retinal disease

This document outlines the procedure for Orthoptists performing intravitreal injections (IVT) of Anti-VEGF or steroid implants. This will include Anti-VEGFs such as:

• Ranibizumab (Lucentis)
• Aflibercept (Eylea)
• Bevacizumab (Avastin)
• Brolucizumab (Beovu)
• Or steroid intravitreal implants such as Dexamethasone (Ozurdex)

Orthoptists must comply with these standards to be insured for professional practice for Age-Related Macular Degeneration (AMD), Diabetic Macular Oedema (DMO), retinal vein
occlusion (RVO), Uveitis, and other macular disorders.

Read document

This policy sets out the management of ophthalmic patients requiring a laser procedure by trained non- medical personnel.

This policy outlines the training and duties involved of those staff outlined to deliver the service. The policy also outlines how compliance with the policy will be monitored.

This document outlines the procedure for orthoptists performing YAG Capsulotomy, YAG peripheral iridotomy and SLT. Orthoptists must comply with these standards in order to be insured for professional practice for the afore-mentioned conditions.

[Also available as Word document]

This document aims to support the appropriate and accurate evaluation and intervention necessary to provide quality patient care in Macular Degeneration Services.